Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022

Expert opinion: Proposed diagnostic and treatment algorithms for Lennox–Gastaut syndrome in adult patients

(2020) Georgia Montouris et al.   EPILEPSY & BEHAVIOR

Rufinamide efficacy and safety in children aged 1–4 years with Lennox–Gastaut syndrome

(2018) Shin Hye Kim et al.   BRAIN & DEVELOPMENT

Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to

(2018) Alexis Arzimanoglou et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

(2017) Ingrid E. Scheffer et al.   EPILEPSIA

Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations

(2017) J. Helen Cross et al.   Frontiers in Neurology

Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial

(2016) Yoko Ohtsuka et al.   EPILEPSY RESEARCH

Rufinamide as an adjunctive therapy for Lennox–Gastaut syndrome: A randomized double-blind placebo-controlled trial in Japan

(2014) Yoko Ohtsuka et al.   EPILEPSY RESEARCH

Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study

(2010) G. Kluger et al.   ACTA NEUROLOGICA SCANDINAVICA

Childhood Epileptic Encephalopathy with Diffuse Slow Spike-Waves (otherwise known as “Petit Mal Variant”) or Lennox Syndrome

(2010) H. GASTAUT et al.   EPILEPSIA

Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology

(2008) Alexis Arzimanoglou et al.   LANCET NEUROLOGY

Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome

(2008) T. Glauser et al.   NEUROLOGY